Joseph Elijah

Joseph Elijah is an Assistant Clinical Professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University and a Clinical Pharmacist Specialist in Gynecologic Oncology at Massachusetts General Hospital. He holds a Doctor of Pharmacy (with Highest Distinction) from the University of Michigan and a Bachelor of Science in Biological Sciences (Summa Cum Laude) from Oakland University. He completed PGY1 and PGY2 residencies in hematology/oncology.

Dr. Elijah's research bridges clinical practice and oncology pharmacotherapy, focusing on:

• Real-world safety/efficacy of immunotherapies and oral oncolytics
• Solid tumor malignancies and targeted therapies
• Pharmacotherapeutic outcomes in special populations

His recent publications (2022-2024) demonstrate a strong emphasis on real-world clinical applications, including pharmacotherapy optimization for breast/lung cancer, CFTR modulators in special populations, and toxicity management. Trends include immunotherapy safety profiling, real-world drug effectiveness studies, and evidence synthesis across oncology and chronic disease.

Awards & Honors:

• Doctor of Pharmacy with Highest Distinction (University of Michigan)
• Bachelor of Science Summa Cum Laude (Oakland University)

He serves as Faculty Co-advisor for the Student Society of Health System Pharmacy and participates in institutional committees including the MGH Oncology P&T Subcommittee.